Back to User profile » Prof. Dr. Fabio Fabbian
Papers published by Prof. Dr. Fabio Fabbian:
Detection of Financial Toxicity in Italian Uremic Patients: A Single Center Cross-Sectional Study
Di Maria A, Capone M, Mancini R, De Giorgi A, Gavazzoli E, Scichilone LM, Veronesi M, Nicoletti S, Fabbian F
International Journal of Nephrology and Renovascular Disease 2025, 18:361-371
Published Date: 15 December 2025
Financial Toxicity and Kidney Disease in Children and Adults: A Scoping Review
Siligato R, Gembillo G, De Giorgi A, Di Maria A, Scichilone LM, Capone M, Vinci FM, Nicoletti S, Bondanelli M, Malaventura C, Storari A, Santoro D, Dionisi S, Fabbian F
International Journal of Nephrology and Renovascular Disease 2025, 18:13-25
Published Date: 21 January 2025
Validation and Comparison of a Modified Elixhauser Index for Predicting In-Hospital Mortality in Italian Internal Medicine Wards
De Giorgi A, Di Simone E, Cappadona R, Boari B, Savriè C, López-Soto PJ, Rodríguez-Borrego MA, Gallerani M, Manfredini R, Fabbian F
Risk Management and Healthcare Policy 2020, 13:443-451
Published Date: 20 May 2020
Should physicians always rely on estimated glomerular filtration rate without knowing the equation?
Fabbian F, Priori D, De Giorgi A
Clinical Interventions in Aging 2017, 12:1309-1311
Published Date: 22 August 2017
Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy
Fedeli U, De Giorgi A, Gennaro N, Ferroni E, Gallerani M, Mikhailidis DP, Manfredini R, Fabbian F
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:443-450
Published Date: 27 January 2017
Reducing the risk of venous thromboembolism using apixaban – patient perspectives and considerations. Should more attention be given to females?
Fabbian F, De Giorgi A, Tiseo R, Zucchi B, Manfredini R
Patient Preference and Adherence 2016, 10:73-80
Published Date: 27 January 2016